If you fill out the "Forgot Password" form but don't get an email to reset your password within 5-10 minutes, please email logistics@ire.org for assistance.
The Wall Street Journal looks at Bristol-Myers' fight to woo patients to a new diabetes medication that isn't substantially different, but is shielded from generic competition. "If the aggressive marketing campaign succeeds, it could mean that tens of thousands of elderly and poor patients--groups for which diabetes has reached epidemic proportions--will keep using the high-priced alternatives from Bristol-Myers."
This file is not available for digital download. IRE members may place an order by emailing rescntr@ire.org
Looks like you haven't made a choice yet.
